Please assess the completion status of the following clinical trial:

Trial Title: A Study of Tongue Conservation Surgery for Oral Tongue Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with histological proof of squamous cell carcinoma of oral tongue~* b. cT2-4, N0-2,M0, by clinical or radiographic examinations~* Either mandibulotomy, mandibulectomy or flap reconstruction is required by standard surgical planning~* Eastern Cooperative Oncology Group (ECOG) performance status of 0-1~* Between 20 and 70 years of age~* Adequate hematopoietic function as defined below:~Hemoglobin \>= 10g/dl Absolute neutrophil count (ANC) \>= 1,500/µL Platelets \>= 100,000/µL~* Adequate organ function as defined below:~Total bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine \<= 1.5 x upper limit of normal Creatinine clearance \> 50 ml/min~* Signed study-specific consent form prior to study entry~Exclusion Criteria:~* Patients received gross oral tongue tumor resection before evaluation~* Primary subsites other than oral tongue~* Histologic diagnosis other than squamous cell carcinoma~* Patient with synchronous primary cancers (within 6 months)~* Clinical or radiographic findings as below:~T1 tumors Gross invasion to mandible, tonsil or \>1/3 base of tongue N3 disease or distant metastasis (M1)~* Prior head and neck chemotherapy or radiotherapy~* Prior esophageal cancer history~* Active cardiac disease defined as: unstable angina, uncontrolled arrhythmia, myocardial infarction within 6 months.~* Severe chronic obstructive pulmonary disease (COPD) requiring ≥ 3 hospitalizations over the past year~* Mental status not fit for clinical trial.~* Pregnant or breast feeding women, or women of child-bearing potential unless using a reliable and appropriate contraceptive method.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Induction chemotherapy (Type: EXPERIMENTAL): Induction chemotherapy will be given every 21 days, with the DCU regimen, followed by tongue conservation surgery, and postoperative CCRT as indicated.

Based on this trial design, predict the completion outcome and termination type (if applicable).